Product Information
LOTEMAX 0.5% OPHTHALMIC GEL is a brand product labeled by Bausch & Lomb Incorporated, priced at $49.5683 per GM under NDC 24208050307. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208050307
Classification
Brand
Dosage Form
GEL
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA202872On Market Since
10/12/2012
Pharmacological Classes
Price Statistics
The NADAC for LOTEMAX 0.5% OPHTHALMIC GEL has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 110.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.5683 per GM |
|---|---|
| All-time high | $49.9549 (May 15, 2024) |
| All-time low | $23.5591 (Nov 28, 2013) |
| 52-week high | $49.7212 |
| 52-week low | $49.5605 |
| Median price | $38.7476 |
| Average price | $38.3233 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOTEMAX 0.5% OPHTHALMIC GEL?
The current National Average Drug Acquisition Cost (NADAC) for LOTEMAX 0.5% OPHTHALMIC GEL, manufactured by Bausch & Lomb Incorporated, is $49.5683 per GM (NDC 24208050307), effective Jun 24, 2026.
How has the price of LOTEMAX 0.5% OPHTHALMIC GEL changed over time?
Over the history we have for it, the NADAC for LOTEMAX 0.5% OPHTHALMIC GEL has risen 110.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOTEMAX 0.5% OPHTHALMIC GEL?
Since Nov 28, 2013, the NADAC for LOTEMAX 0.5% OPHTHALMIC GEL has ranged from a low of $23.5591 (Nov 28, 2013) to a high of $49.9549 (May 15, 2024), with a median of $38.7476 per GM.
Are there cheaper alternatives to LOTEMAX 0.5% OPHTHALMIC GEL?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LOTEPREDNOL 0.5% OPHTHALMC GEL, is $14.2657 per GM — about 71% below LOTEMAX 0.5% OPHTHALMIC GEL.
Who manufactures LOTEMAX 0.5% OPHTHALMIC GEL?
LOTEMAX 0.5% OPHTHALMIC GEL (NDC 24208050307) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.
Related Drugs
Same classification